Science policy news: weekly roundup: January 8, 2016 ?>

Science policy news: weekly roundup: January 8, 2016

The roundup is formatted with the title of the story, followed by the news source in parentheses and a brief summary. If you find a particularly interesting article, please send it to for inclusion in next week’s roundup.

The U.S. House of Representatives and Senate passed the fiscal 2016 omnibus spending bill. The National Institutes of Health is set to receive a $2 billion budget increase.

Omnibus budget bill recognizes importance of scientific research (The Hill)

Research agencies revel in final 2016 budget (Science)

Congress is finally investing in health (The Washington Post)

Deliver a victory in cancer research (The Hill)


The gene-editing technology CRISPR-Cas9 sparked debate last year over the bioethical implications of editing the human germline.

Gene Editing Tool CRISPR Is Making Scientists Face The Hard Questions (Newsy)


The National Institutes of Health has called for a moratorium on funding for human-animal stem cell chimera research.

U.S. Research Farms growing human organs inside pigs and sheep (Digital Journal)


The U.S. government released changes to the Federal Policy for Protection of Human Subjects more commonly known as the Common Rule. Rebecca Skloot, author of The Immortal Life of Henrietta Lacks, responds to the proposed changes to the Common Rule.

Your Cells. Their Research. Your Permission? (The New York Times)

No, Donating Your Leftover Tissue To Research Is Not Like Letting Someone Rifle Through Your Phone (Forbes)


House Democrats have asked for communication records between the National Football League and the Foundation for the National Institutes of Health concerning a $30 million donation in 2012.

House Democrats seek records relating to alleged NFL ‘veto power’ in NIH concussion study (The Washington Post)

Dems fret over NFL’s ‘veto power’ on medical research (The Hill)

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.